[Skip to Content]
[Skip to Content Landing]
March 1992

Level of Blood Pressure and Risk of Myocardial Infarction Among Treated Hypertensive Patients

Author Affiliations

From the Departments of Epidemiology (Drs McCloskey, Psaty, and Koepsell), Medicine (Drs Psaty and Aagaard), Health Services (Dr Koepsell), and Pharmacology (Dr Aagaard), University of Washington, Seattle.

Arch Intern Med. 1992;152(3):513-520. doi:10.1001/archinte.1992.00400150045008

To examine the association between the level of treated blood pressure and the incidence of myocardial infarction, we conducted a population-based case-control study of 912 members of a health maintenance organization who were receiving standard clinical treatment for hypertension. We found a J-shaped relationship between the most recently measured diastolic blood pressure and the risk of myocardial infarction, the lowest risk occurring at 84 mm Hg. The relative risk of myocardial infarction at 60 mm Hg was 2.07 (95% confidence interval, 0.86 to 5.01), and at 100 mm Hg, 1.45 (95% confidence interval, 1.02 to 2.06). Treated systolic pressure bore a linear relationship to the risk of infarction. We conclude that the optimum target range for diastolic blood pressure in hypertensive patients may be 84 to 90 mm Hg. Levels outside this range may be associated with increased risk of myocardial infarction.

(Arch Intern Med. 1992;152:513-520)

Lew EA.  High blood pressure, other risk factors and longevity: the insurance viewpoint .  Am J Med. 1973;55:281-294.Crossref
Society of Actuaries.  Build and Blood Pressure Study . Chicago, Ill: Society of Actuaries; 1959.
Anderson TW.  Re-examination of some of the Framingham blood pressure data .  Lancet. 1978;2:1139-1141.Crossref
Veterans Administration Cooperative Study Group on Antihypertensive Agents.  Effects of treatment on morbidity in hypertension, II: results in patients with diastolic blood pressure averaging 90 through 114 mm Hg .  JAMA. 1970;213:1143-1152.Crossref
Smith WM, US Public Health Service Hospitals Cooperative Study Group.  Treatment of mild hypertension: results of a ten-year intervention trial .  Circ Res. 1977;40( (suppl I) ):98-105.Crossref
Hypertension Detection and Follow-up Program Cooperative Group.  Reduction in mortality of persons with high blood pressure, including mild hypertension: part 1 .  JAMA. 1979;242:2562-2571.Crossref
Australian National Blood Pressure Study Management Committee.  The Australian therapeutic trial in mild hypertension .  Lancet. 1980;1:1261-1267.
Helgeland A.  Treatment of mild hypertension: a five year controlled drug trial (the Oslo study) .  Am J Med. 1980;69:725-732.Crossref
Multiple Risk Factor Intervention Trial Research Group.  Multiple Risk Factor Intervention Trial: risk factor changes and mortality results .  JAMA. 1982;248:1465-1477.Crossref
Medical Research Council Working Party.  MRC trial of treatment of mild hypertension: principal results .  BMJ. 1985;291:97-104.Crossref
Samuelsson O, Wilhelmsen L, Andersson OK, Pennert K, Berglund G.  Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension .  JAMA. 1987;258:1768-1776.Crossref
MacMahon SW, Cutler JA, Furberg CD, Payne GH.  The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials .  Prog Cardiovasc Dis. 1986;29( (suppl 1) ):99-118.Crossref
Stewart IMG.  Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension .  Lancet. 1979;1:861-865.Crossref
Cruickshank JM, Thorp JM, Zacharias FJ.  Benefits and potential harm of lowering high blood pressure .  Lancet. 1987;1:581-583.Crossref
Culverwell M.  Emphasis on step-care, neglect of J-curve cited as problems with JNC-4 .  Cardiovasc Rev Rep. 1988;9:13-16.
Psaty BM, Koepsell TD, LoGerfo JP, Wagner EH, Inui TS.  β-Blockers and the primary prevention of coronary heart disease in patients with high blood pressure .  JAMA. 1989;261:2087-2094.Crossref
Jick H, Watkins RN, Hunter JR, et al.  Replacement estrogens and endometrial cancer .  N Engl J Med. 1979;300:218-222.Crossref
World Health Organization.  Myocardial infarction community registers: results of a WHO international collaborative study coordinated by the regional office for Europe .  Public Health Eur. 1977;5:157-161.
Folsom AR, Marin O, Gillum RF, Kottke TE, Lohman W, Jacobs JR.  Out-of-hospital coronary death in an urban population: validation of death certificate diagnosis: the Minnesota Heart Survey .  Am J Epidemiol. 1987;125:1012-1015.
Shephard DS, Neutra ME.  A pitfall in sampling medical visits .  Am J Public Health. 1977;67:743-750.Crossref
Sleight P.  Blood pressures, hearts, and U-shaped curves .  Lancet. 1988;1:235.Crossref
Cruickshank JM, Thorp JM, Zacharias FJ.  Heart attacks and lowering of blood pressure .  Lancet. 1987;1:1154.Crossref
Cruickshank JM, Thorp JM, Zacharias FJ.  How far to lower blood pressure?  Lancet. 1987;2:695.Crossref
Alderman MH, Ooi WL, Madhavan S, Cohen H.  Treatment-induced blood pressure reduction and the risk of myocardial infarction .  JAMA. 1989;262:920-924.Crossref
Staessen J, Bulpitt C, Clement D, et al.  Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly .  BMJ. 1989;298:1552-1556.Crossref
Wilhelmsen L, Berglund G, Elmfeldt D, et al.  Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial .  J Hypertens. 1987;5:561-572.Crossref
 How far to lower blood pressure?  Lancet. 1987;2:251-252. Editorial.
Lindholm L, Lanke J, Bengtsson B, Ejlertsson G, Thulin T, Schersten B.  Both high and low blood pressures risk indicators of death in middle aged males: isotonic regression of blood pressure on age applied to data from a 13-year prospective study .  Acta Med Scand. 1985;228:473-480.
Coope J, Warrender TS.  Lowering blood pressure .  Lancet. 1987;1:1380.Crossref
Berglund G, Samuelsson O.  Lowered blood pressure and the J-shaped curve .  Lancet. 1987;1:1154-1155.Crossref
Cooper SP, Hardy RJ, Labarthe DR, et al.  The relation between degree of blood pressure reduction and mortality among hypertensives in the Hypertension Detection and Follow-up Program .  Am J Epidemiol. 1988;127:387-403.
Green KG.  The role of hypertension and downward changes of blood pressure in the genesis of coronary atherosclerosis and ischemic attacks .  Am Heart J. 1982;103:579-582.Crossref
Campbell BC.  How far to lower blood pressure?  Lancet. 1987;2:695.
Floras JS.  Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischemia .  Lancet. 1988;2:994-996.Crossref
Strandgaard S, Haunso S.  Why does antihypertensive treatment prevent stroke but not myocardial infarction?  Lancet. 1987;2:658-661.Crossref
Culverwell M.  Study sees excessive BP reduction raising risk of MI .  Cardiovasc Rev Rep. 1988;9:16-17.
Floras JS, Jones JV, Hassan MO, Sleight P.  Ambulatory blood pressure during once-daily randomized double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol .  BMJ. 1982;285:1387-1392.Crossref